Skip to main content
SpringerLink
Log in

Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

We aimed to assess the efficacy of stereotactic irradiation for patients with recurrent high-grade glioma (HGG) and identify predictive factors of progression-free survival (PFS) and overall survival (OS) following reirradiation. We identified 32 patients with recurrent brain HGG who had been treated with either single-dose (stereotactic radiosurgery) or fractionated stereotactic radiotherapy between April 2008 and October 2015. Median follow up was 21.4 months (range 12.9–23.2) and median PFS was and 3.3 months (95% CI [2.3–4.7]), respectively. OS was 90.40% (95% CI [73.09–96.80]) at 6 months and 79.55% (95% CI [59.9–90.29]) at 12 months. Univariate analysis showed that biological effective dose at isocenter ≤ 76 Gy was a poor prognostic factor for both OS (83.33 vs. 100% at 6 months, p = 0.032) and median PFS (2.7 vs. 4.7 months, p = 0.025), as was gross tumor volume (GTV) above 1 cm3 for OS (86.15 vs. 94.12% at 6 months, p = 0.043). Contact with the subventricular zone (SVZ) was also a poor prognostic factor for median PFS (2.3 vs. 4.7 months, p = 0.002). Multivariate analysis showed that SVZ contact remained a poor prognostic factor for PFS (hazard ratio = 3.44, 95% CI [1.21–9.82], p = 0.021). Results suggest that reirradiation is a safe and effective treatment option for recurrent HGG in patients with a good Karnosfsky Performance Scale score, a long progression-free interval since first radiation and limited GTV, and that contact to SVZ is a strong prognostic factor for PFS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507. https://doi.org/10.1056/NEJMra0708126

    Article  CAS  PubMed  Google Scholar 

  2. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. https://doi.org/10.1016/S1470-2045(09)70025-7

    Article  CAS  PubMed  Google Scholar 

  3. Darefsky AS, King JT, Dubrow R (2012) Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of surveillance, epidemiology, and end results registries. Cancer 118:2163–2172. https://doi.org/10.1002/cncr.26494

    Article  PubMed  Google Scholar 

  4. Koshy M, Villano JL, Dolecek TA et al (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107:207–212. https://doi.org/10.1007/s11060-011-0738-7

    Article  PubMed  Google Scholar 

  5. Levin VA (1999) Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading. Neuro Oncol 1:69–80

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Barbagallo GMV, Jenkinson MD, Brodbelt AR (2008) “Recurrent” glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22:452–455. https://doi.org/10.1080/02688690802182256

    Article  PubMed  Google Scholar 

  7. Soults CB, Canute GS, Ryken TC (1998) Evidence-based review of the role of reoperation in the management of malignant glioma. Neurosurg Focus 4:e11

    Article  CAS  PubMed  Google Scholar 

  8. Weller M, van den Bent M, Hopkins K et al (2014) EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 15:e395–e403. https://doi.org/10.1016/S1470-2045(14)70011-7

    Article  PubMed  Google Scholar 

  9. Amichetti M, Amelio D (2011) A review of the role of re-irradiation in recurrent high-grade glioma (HGG). Cancers 3:4061–4089. https://doi.org/10.3390/cancers3044061

    Article  PubMed  PubMed Central  Google Scholar 

  10. Martínez-Carrillo M, Tovar-Martín I, Zurita-Herrera M et al (2014) Salvage radiosurgery for selected patients with recurrent malignant gliomas. Biomed Res Int 2014:657953. https://doi.org/10.1155/2014/657953

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ryu S, Buatti JM, Morris A et al (2014) The role of radiotherapy in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline. J Neurooncol 118:489–499. https://doi.org/10.1007/s11060-013-1337-6

    Article  CAS  PubMed  Google Scholar 

  12. Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972. https://doi.org/10.1200/JCO.2009.26.3541

    Article  PubMed  Google Scholar 

  13. Gupta T, Nair V, Jalali R (2014) Stem cell niche irradiation in glioblastoma: providing a ray of hope? CNS Oncol 3:367–376. https://doi.org/10.2217/cns.14.39

    Article  CAS  PubMed  Google Scholar 

  14. Lim DA, Cha S, Mayo MC et al (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9:424–429. https://doi.org/10.1215/15228517-2007-023

    Article  PubMed  PubMed Central  Google Scholar 

  15. Adeberg S, König L, Bostel T et al (2014) Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone. Int J Radiat Oncol Biol Phys 90:886–893. https://doi.org/10.1016/j.ijrobp.2014.07.027

    Article  PubMed  Google Scholar 

  16. Jafri NF, Clarke JL, Weinberg V et al (2013) Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol 15:91–96. https://doi.org/10.1093/neuonc/nos268

    Article  CAS  PubMed  Google Scholar 

  17. Niyazi M, Siefert A, Schwarz SB et al (2011) Therapeutic options for recurrent malignant glioma. Radiother Oncol 98:1–14. https://doi.org/10.1016/j.radonc.2010.11.006

    Article  PubMed  Google Scholar 

  18. Elliott RE, Parker EC, Rush SC et al Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg 76:128–140. https://doi.org/10.1016/j.wneu.2010.12.053. (discussion 61–62)

  19. Kondziolka D, Flickinger JC, Bissonette DJ et al (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41:776–783. (discussion 783–785)

    Article  CAS  PubMed  Google Scholar 

  20. Fogh SE, Andrews DW, Glass J et al (2010) Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 28:3048–3053. https://doi.org/10.1200/JCO.2009.25.6941

    Article  PubMed  PubMed Central  Google Scholar 

  21. Combs SE, Widmer V, Thilmann C et al (2005) Stereotactic radiosurgery (SRS). Cancer 104:2168–2173. https://doi.org/10.1002/cncr.21429

    Article  PubMed  Google Scholar 

  22. Shrieve DC, Alexander E, Wen PY et al (1995) Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275–282. (discussion 282–284)

    Article  CAS  PubMed  Google Scholar 

  23. Hsieh PC, Chandler JP, Bhangoo S et al (2005) Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 57:684–692

    Article  PubMed  Google Scholar 

  24. Mahajan A, McCutcheon IE, Suki D et al (2005) Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme. J Neurosurg 103:210–217. https://doi.org/10.3171/jns.2005.103.2.0210

    Article  PubMed  Google Scholar 

  25. Kong D-S, Lee J-I, Park K et al (2008) Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer 112:2046–2051. https://doi.org/10.1002/cncr.23402

    Article  PubMed  Google Scholar 

  26. Combs SE, Edler L, Rausch R et al (2013) Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma. Acta Oncol 52:147–152. https://doi.org/10.3109/0284186X.2012.692882

    Article  PubMed  Google Scholar 

  27. Niyazi M, Flieger M, Ganswindt U et al (2014) Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort. Radiat Oncol 9:128. https://doi.org/10.1186/1748-717X-9-128

    Article  PubMed  PubMed Central  Google Scholar 

  28. Larson DA, Gutin PH, McDermott M et al (1996) Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys 36:1045–1053

    Article  CAS  PubMed  Google Scholar 

  29. Lederman G, Wronski M, Arbit E et al (2000) Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 23:155–159

    Article  CAS  PubMed  Google Scholar 

  30. Noël G, Ben Ammar CN, Feuvret L et al (2004) Results of salvage stereotactic radiosurgery in 14 patients with grade III or IV gliomas. Rev Neurol (Paris) 160:539–545

    Article  Google Scholar 

  31. Cho KH, Hall WA, Gerbi BJ et al (1999) Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 45:1133–1141

    Article  CAS  PubMed  Google Scholar 

  32. Fokas E, Wacker U, Gross MW et al (2009) Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 185:235–240. https://doi.org/10.1007/s00066-009-1753-x

    Article  PubMed  Google Scholar 

  33. Quiñones-Hinojosa A, Chaichana K (2007) The human subventricular zone: a source of new cells and a potential source of brain tumors. Exp Neurol 205:313–324. https://doi.org/10.1016/j.expneurol.2007.03.016

    Article  PubMed  Google Scholar 

  34. Doetsch F, Caillé I, Lim DA et al (1999) Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97:703–716

    Article  CAS  PubMed  Google Scholar 

  35. Alvarez-Buylla A, Garcia-Verdugo JM (2002) Neurogenesis in adult subventricular zone. J Neurosci 22:629–634

    CAS  PubMed  Google Scholar 

  36. Adeberg S, Bostel T, König L et al (2014) A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol 9:95. https://doi.org/10.1186/1748-717X-9-95

    Article  PubMed  PubMed Central  Google Scholar 

  37. Chaichana KL, McGirt MJ, Frazier J et al (2008) Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 89:219–224. https://doi.org/10.1007/s11060-008-9609-2

    Article  PubMed  Google Scholar 

  38. Aguirre A, Gallo V (2004) Postnatal neurogenesis and gliogenesis in the olfactory bulb from NG2-expressing progenitors of the subventricular zone. J Neurosci 24:10530–10541. https://doi.org/10.1523/JNEUROSCI.3572-04.2004

    Article  CAS  PubMed  Google Scholar 

  39. Evers P, Lee PP, DeMarco J et al (2010) Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma. BMC Cancer 10:384. https://doi.org/10.1186/1471-2407-10-384

    Article  PubMed  PubMed Central  Google Scholar 

  40. Slotman BJ, Eppinga WSC, de Haan PF, Lagerwaard FJ (2011) Is irradiation of potential cancer stem cell niches in the subventricular zones indicated in GBM? Int J Radiat Oncol 81:S184. https://doi.org/10.1016/j.ijrobp.2011.06.328

    Article  Google Scholar 

  41. Gupta T, Nair V, Paul SN et al (2012) Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma? J Neurooncol 109:195–203. https://doi.org/10.1007/s11060-012-0887-3

    Article  PubMed  Google Scholar 

  42. Chen L, Guerrero-Cazares H, Ye X et al (2013) Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection. Int J Radiat Oncol Biol Phys 86:616–622. https://doi.org/10.1016/j.ijrobp.2013.02.014

    Article  PubMed  PubMed Central  Google Scholar 

  43. Elicin O, Inac E, Uzel EK et al (2014) Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial. J Neurooncol 118:413–419. https://doi.org/10.1007/s11060-014-1424-3

    Article  CAS  PubMed  Google Scholar 

  44. Lee P, Eppinga W, Lagerwaard F et al (2013) Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis. Int J Radiat Oncol Biol Phys 86:609–615. https://doi.org/10.1016/j.ijrobp.2013.01.009

    Article  PubMed  Google Scholar 

  45. Khalifa J, Tensaouti F, Lusque A et al (2017) Subventricular zones: new key targets for glioblastoma treatment. Radiat Oncol 12:67. https://doi.org/10.1186/s13014-017-0791-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ellison DW, Kocak M, Figarella-Branger D et al (2011) Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10:7. https://doi.org/10.1186/1477-5751-10-7

    Article  PubMed  PubMed Central  Google Scholar 

  47. Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

    Article  PubMed  Google Scholar 

  48. Flieger M, Ganswindt U, Schwarz SB et al (2014) Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option. J Neurooncol 117:337–345. https://doi.org/10.1007/s11060-014-1394-5

    Article  CAS  PubMed  Google Scholar 

  49. Khasraw M, Ameratunga M, Grommes C (2014) Bevacizumab for the treatment of high-grade glioma: an update after phase III trials. Expert Opin Biol Ther 14:729–740. https://doi.org/10.1517/14712598.2014.898060

    Article  CAS  PubMed  Google Scholar 

  50. Hundsberger T, Brügge D, Putora PM et al (2013) Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 112:133–139. https://doi.org/10.1007/s11060-013-1044-3

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse-Oncopôle, 1 Avenue Irène Joliot-Curie, 31059, Toulouse, France

    J. Attal, C. Lanaspeze, L. Vieillevigne & E. Cohen-Jonathan Moyal

  2. Department of Biostatistics, Institut Universitaire du Cancer de Toulouse-Oncopôle, 1 Avenue Irène Joliot-Curie, 31059, Toulouse, France

    L. Chaltiel

  3. Regional Center for Stereotactic Radiosurgery, CHU Rangueil, Avenue Jean-Poulhès, 31052, Toulouse, France

    V. Lubrano & I. Latorzeff

  4. Department of Neurosurgery, CHU de Toulouse, Université Paul-Sabatier, 31059, Toulouse, France

    V. Lubrano & J. C. Sol

  5. Department of Oncology-Radiotherapy, Groupe ONCORAD Garonne, Clinique Pasteur, 31300, Toulouse, France

    I. Latorzeff

  6. INSERM U1037, Cancer Research Center of Toulouse (CRCT), 31000, Toulouse, France

    E. Cohen-Jonathan Moyal

  7. Université Toulouse III Paul Sabatier, 31300, Toulouse, France

    E. Cohen-Jonathan Moyal

Authors
  1. J. Attal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Chaltiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Lubrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. C. Sol
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Lanaspeze
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Vieillevigne
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Latorzeff
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Cohen-Jonathan Moyal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Attal.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Attal, J., Chaltiel, L., Lubrano, V. et al. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation. J Neurooncol 136, 413–419 (2018). https://doi.org/10.1007/s11060-017-2669-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-017-2669-4

Keywords

Search

Navigation